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Background: Maternal mortality and morbidity remains high in many low- and middle-income countries (LMIC).
Gestational Diabetes Mellitus (GDM) represents an underestimated and unrecognised impediment to optimal
maternal health in LMIC; left untreated – it also has severe consequences for the offspring. A better understanding
of the barriers hindering detection and treatment of GDM is needed. Based on experiences from World Diabetes
Foundation (WDF) supported GDM projects this paper seeks to investigate societal and health system barriers to
such efforts.
Methods: Questionnaires were filled out by 10 WDF supported GDM project partners implementing projects in
eight different LMIC. In addition, interviews were conducted with the project partners. The interviews were analysed
using content analysis.
Results: Barriers to improving maternal health related to GDM nominated by project implementers included lack of
trained health care providers - especially female doctors; high staff turnover; lack of standard protocols,
consumables and equipment; financing of health services and treatment; lack of or poor referral systems, feedback
mechanisms and follow-up systems; distance to health facility; perceptions of female body size and weight gain/
loss in relation to pregnancy; practices related to pregnant women’s diet; societal negligence of women’s health;
lack of decision-making power among women regarding their own health; stigmatisation; role of women in society
and expectations that the pregnant woman move to her maternal home for delivery.
Conclusions: A number of barriers within the health system and society exist. Programmes need to consider and
address these barriers in order to improve GDM care and thereby maternal health in LMIC.
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Although maternal mortality and morbidity have received
increased attention in the last two decades it still remains a
huge public health challenge in many countries. According
to the World Health Organization (WHO), approximately
1000 women die from preventable causes related to preg-
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[1]. Haemorrhage, hypertensive disorders, obstructed
labour and infection/sepsis are among the leading global
causes of maternal mortality [2]. Gestational diabetes
mellitus (GDM) directly or indirectly increases the risk
of all the above conditions but is rarely mentioned
among the causes of maternal mortality and morbidity.
Hyperglycaemia may affect <1-19% of pregnancies in
LMIC [3-14] and is one of the most common medical
conditions affecting pregnancy. Hyperglycaemia during
pregnancy, (GDM and pre-gestational diabetes) increases
the risk of maternal- and peri-natal mortality, obstructeded Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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[15]. In countries where appropriate care for obstetrical
emergencies is lacking, GDM may have particularly severe
consequences for the health and well-being of the mother
and child. GDM therefore represents an underestimated
and unrecognised impediment to optimal maternal and
neonatal health in LMIC.
Studies have shown that it is possible to reduce the risk
of adverse pregnancy outcomes for women with GDM if
proper management is initiated and tight glycemic control
obtained [16,17]. Cost benefit of screening women for
GDM particularly with the recent introduction of the
International Association of Diabetes and Pregnancy
Study Groups (IADPSG) guideline with the likelihood of
more women being identified and requiring care is being
hotly debated; these calculations are dependent on the
intervention, the underlying prevalence, opportunity cost,
local costing etc. Models that take into account not only
the immediate pregnancy outcomes but the potential for
future prevention of type 2 diabetes in the mother and off-
spring show cost saving or a very favourable cost effective-
ness ratio [18]. Addressing GDM through early detection
and proper management therefore constitutes an oppor-
tunity to improve maternal health. In the absence of an
international consensus, multiple different guidelines on
screening and diagnosis of GDM have existed for a long
time. This may be changing with the publication of the
IADPSG recommendations. While an international con-
sensus on screening and diagnosis for GDM is welcome, it
fails to take into account feasibility and applicability in
low resource settings to ensure wider usage. The barriers
and challenges to screening and diagnosis and the applic-
ability of various tests have been described by us in a re-
cent paper [19]. It is recommended that women with
GDM be screened for diabetes earliest around six weeks
postpartum [20-22]. After delivery most women with
GDM return to normal glucose regulation, but continue
to have a high risk of future diabetes, and some will be
found to have overt diabetes, impaired fasting glucose or
impaired glucose tolerance. To be able to identify these
women and provide them all with appropriate treatment
or preventive care is another opportunity and challenge.
To be able to plan appropriate strategies to address these
issues will require better understanding of the barriers
currently hindering detection and treatment of GDM.
This paper seeks to investigate societal and health system
barriers hindering such efforts based on experiences
gained from GDM projects supported by the World
Diabetes Foundation (WDF).
Methods
From 2002 to 2010 WDF granted support to 253 pro-
jects. In order for a project to be included in this study
it had to address GDM and begun implementation ofactivities before March 2011. Eleven projects from eight
different LMIC qualified and were included in the study.
Questionnaires were sent to the project partners and the
partners were asked to participate in an interview. As
one project partner was implementing two of the
included projects a total of 10 partners participated. All
10 responded to the questionnaire and interviews were
conducted face-to-face with three partners, over the
phone with six partners and via email with one partner.
Participation in the study was voluntary and before the
interview the purpose of it was explained to the respon-
dents and consent to participate in the interview
obtained. Permission to audio record the interview was
also requested from and given by the nine project part-
ners that were interviewed face-to-face or via telephone.
Upon enquiry with the Danish Biomedical Research Eth-
ics Committee we were assured that this study was ex-
empt from ethical approval as it was a questionnaire and
interview study without the use of human biological
material.
The questionnaire was designed to obtain information
about the projects, e.g. whether the project was imple-
mented in public or private health facilities (see Additional
file 1), with the intention to get a better understanding
of the projects and thereby the context of the qualita-
tive data. The interview-guide employed for the inter-
views was semi-structured and had mainly open-ended
questions delving into barriers and challenges related to
screening, diagnosis, treatment and follow-up of GDM
(see Additional file 2). The list of questions and appro-
priate probes were drafted by KKN and AK based on
literature search, previous reported challenges men-
tioned by WDF project partners and broad issues, e.g.
barriers in the health system, which we wanted to cover
in the interviews. Finally, some specific information
from the questionnaire also triggered questions during
the interview.
Content analysis was used to analyse the interviews,
which were recorded and transcribed immediately after
they were conducted, making the analysis an ongoing ac-
tivity as it allowed us to be more aware of emerging
themes that we could probe further during later inter-
views. The interviews and questionnaires were then
searched for meaning units and coded by developing cat-
egories. The categories were reviewed to make sure that
no categories were describing the same phenomena, and
subsequently organised into core themes.
Results
Five of the projects are implemented in India, two in Latin
America and the Caribbean, two in Sub-Saharan Africa,
and one in China and Sudan, respectively. Two projects,
Kenya and Cuba, are implemented by either the Ministry of
Health or national government institutions. The remaining
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national research institutions, hospitals or private initiatives;
however, all projects are collaborating with national or state
health authorities. Six of the projects are solely implemen-
ted at public/government health centres. The other five
projects are implemented at both public/government and
private (including faith-based) health centres. See Tables 1
and 2 for more information about the projects.Health system and societal barriers to GDM detection and
treatment
A number of health system and societal barriers were
described by the informants. An overview of the barriers
is given in Figure 1.Table 1 Overview of projects
Country Project title Implementing
India, Tamil
Nadu
Gestational Diabetes Mellitus – Awareness
Creation, Prevention and Control in the
Community
Dr. V. Seshiah D
Research Instit
Cuba Completion of the Diabetes and Pregnancy






Sudan Gestational Diabetes Mellitus Control
Project
Sudan Fertility
Cameroon Improving screening, management, and
outcome of gestational diabetes in urban





Extension of project on Gestational
Diabetes Mellitus – Awareness Creation,
Prevention and Control in the Community
Dr. V. Seshiah D
Research Instit
India, Karnataka Addressing Gestational Diabetes Mellitus in




Jamaica/Panama Strengthening Diagnosis and Treatment of
Gestational Diabetes through Reinforced















A Multi Media Approach for Awareness
Generation on Gestational Diabetes and it’s
Management in selected districts of India
Jagran Pehel
China China GDM centers – establishment and
training dissemination
Peking Univers
India, Punjab Gestational Diabetes in Punjab Deep HospitalHealth system barriers
Lack of trained health care providers and high staff
turnover
A main barrier within the health system was the short-
age of trained health care providers. This barrier involves
two dimensions: having enough health care providers to
take care of the patient load and having health care pro-
viders with adequate training to provide quality care.
The first issue is the absolute critical shortage of
health workers. The WHO estimates that 4.3 million
more health workers are required to meet the health
Millennium Development Goals (MDGs)—a global com-
pact to reduce child mortality, improve maternal health,
and combat AIDS, malaria, and other diseases by 2015
[24]. But even this alarmingly high figure significantlypartner Collaborating partners
iabetes Care and
ute
Department of Public Health & Preventive
Medicine, Tamil Nadu; The Municipal Corporation





The Maternity and Infant Program; the National
Group of Obstetrics and Gynaecology; the National
Group of Endocrinology; the National Committee
on Diabetes and Pregnancy.








Centre for Health Education and Development;
Department of Public Health & Preventive
Medicine, Government of Tamil Nadu
anda Youth Prashasa Health Consultants Pvt Ltd
entre for Migration,
velopment





The Kenya Diabetes Association; the Kenya
Diabetes Study Group; Kenya Diabetes Educators;
the World Health Organization
Jagran Prakashan Limited; local government health
departments; Indian Medical Association; Lions
Club; Rotary International; Private health care
facilities.
ity First Hospital Ministry of Health of China; Novo Nordisk (China)
Jagran Pehel; Sri Rama Charitable Hospital; Iqbal
Hospital; Novo Nordisk; Steno Diabetes Center;
Health Strategies International; Government
Medical Colleges in Patiala, Amritsar and Faridkot;
Municipal Corporation in Ludhiana; Department of
Health and Family Welfare in Ludhiana;
Copenhagen University; University of California, San
Francisco.
Table 2 Project achievements, details and country specific maternal mortality ratio
Country Project title Implemented at public/











ratio (per 100 000 live
births) [23]
India, Tamil Nadu Gestational Diabetes Mellitus – Awareness Creation,
Prevention and Control in the Community
Public 12056 1679 2550 200 [140–310]1
Cuba Completion of the Diabetes and Pregnancy Services
Network in all the provincial capitals in Cuba
Public 25066 2747 368 73 [60–87]
Sudan Gestational Diabetes Mellitus Control Project Public 7551 NA 90 730 [380–1400]
Cameroon Improving screening, management, and outcome of
gestational diabetes in urban and rural Sub-Saharan
Africa
Both: 80% public and 20% private 12000 381 450 690 [430–1200]
India, Tamil Nadu Extension of project on Gestational Diabetes Mellitus –
Awareness Creation, Prevention and Control in the
Community
Public 12500 1538 13860 200 [140–310] 1
India, Karnataka Addressing Gestational Diabetes Mellitus in a rural and
tribal Population of Mysore District, India
Both: 15% public and 85% private 2054 20 944 200 [140–310] 1
Jamaica/Panama Strengthening Diagnosis and Treatment of Gestational
Diabetes through Reinforced Maternal and Child
Health Services
Public NA NA 440 110 [77–170]/92 [75–110]
Kenya (National
Programme)




A Multi Media Approach for Awareness Generation on
Gestational Diabetes and it’s Management in selected
districts of India
Both: 25% public and 75% private NA NA 200 200 [140–310] 1
China China GDM centers – establishment and training
dissemination
Public 26459 3230 4725 37 [23–58]
India, Punjab Gestational Diabetes in Punjab Both: 50% public and 50% private 1150 85 300 200 [140–310] 1
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Figure 1 Overview of health system and societal barriers.
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cause the WHO only accounts for shortages in 57 coun-
tries that miss the minimalist target of 2.28 doctors,
nurses, and midwives per 1,000 in the population [25].
This shortage in health resources is further compounded
by prioritisation based on perceptions of importance of a
particular health issue and here GDM often loses the
draw as respondents reported that health care planners/
providers do not consider GDM important enough to
prompt action as it is not part of national disease sur-
veillance reports. When resources are limited only issues
that are part of surveillance systems receive priority and
get resourced.
Traditionally this is an area where the predominant
diseases are the communicable diseases and much is
required for malaria and HIV/AIDS. You will find thatour clinics are so geared for promoting prevention of
maternal to child transmission that trying now to
introduce the issue of GDM takes time.
Respondent from project in Kenya
Two of the respondents from India mentioned that in
their area it is not so much the number of available
health care providers, but more an issue of not having
enough female health care providers, especially female
doctors, as many women do not want to discuss issues
related to reproductive health with male doctors.
The second issue is lack of awareness and inadequate
training of health care providers on GDM and the links
between non-communicable diseases (NCDs) and mater-
nal health. This is another important impediment for
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women who require insulin management this can be
problematic as some respondents reported that health
care providers in general are not sufficiently trained or
confident enough in prescribing insulin.
Our health care personnel in the country are still
afraid of insulin. They still try to stay far away from
insulin, so when they reach a stage where they have to
prescribe insulin it becomes a problem. Only few
doctors would be used to prescribe insulin.
Respondent from project in Cameroon
Also lack of knowledge among health care providers
about proper diet and meal plans for women with GDM
were reported by respondents.
Retaining health care providers, who have received train-
ing in the area of diabetes and GDM, can be challenging as
turnover of staff is quite high in some places particularly
when there are limited human resources and if the learning
has not been passed on to other health care providers.
It is mainly a problem with staff. Trained staff that
might be posted elsewhere, so you are not sure that
people you’ve trained will still be there one, two, three
years later; so how to ensure that the message will go
across to the whole team – that is a bit challenging.
Respondent from project in Cameroon
Lack of standard protocols
Another barrier mentioned is the lack of standard proto-
cols for diagnosis and management of GDM. Conse-
quently, some of the projects have developed such
protocols themselves; yet, some of the respondents also
report challenges with the development, dissemination
and/or implementation of such protocols. One project
for example initially intended to base their protocol on
international guidelines, but discovered that many
women were unable to provide the required information,
making it very complicated to screen based on risk fac-
tors as recommended in the guidelines of some organi-
sations e.g. American Diabetes Association 2010, Fifth
International Workshop-Conference on GDM 2007 and
National Institute for Health and Clinical Excellence
2008 [22,26,27]. These challenges have been explored in
greater detail by us in an earlier paper [19].
Lack of consumables and equipment
Lack of test consumables and equipment were also high-
lighted as health system barriers for screening, detection
and management of GDM. Materials needed for thisinclude laboratory equipment, glucose solution, gluc-
ometers, equipment for monitoring foetal development as
well as instruments, i.e. computers and software, for
record keeping and administration. Without the neces-
sary equipment and consumables it is next to impos-
sible to ensure proper care and follow-up.
Field staff can be trained, field staff can be motivated,
field staff can be encouraged and become willing to
do it, as long as they have the way and tools to do it.
It is no good asking field staff to do something that
they don’t have the equipment to do, the time to do
or the knowledge to do.
Respondent from project in Jamaica and Panama
Financing of health services and treatment
Another issue is the lack of health financing for screen-
ing and treatment, i.e. when the patient is obliged to
pay a fee for screening and/or treatment services and
consumables. However low the cost, paying out of
pocket is a barrier to access care and adhere to treat-
ment for many women with GDM in LMIC. Not only is
the cost of medication a barrier but even the cost of
following the recommended diet can be challenging for
many.
The other obstacle will always be whether changing a
diet is economically feasible. I think we should really
pay a lot of attention to that when we are dealing with
GDM.
Respondent from project in Jamaica and Panama
In addition, one of the respondents from India noted
that although services within the government health care
system may be offered free of charge or at subsidised
rates, the lack of trained health care providers in reality
leaves some women with GDM with no choice other
than to seek care at private health facilities with consid-
erably higher costs and this option is not possible for
women with GDM belonging to the poorer segments of
society. Thus, the cost of the treatment as well as fee for
services, i.e. consultations and tests, in some contexts
constitutes a barrier for proper treatment; health finan-
cing mechanisms therefore not only need to address ac-
cess and costs, but also quality and comprehensiveness
of the programmes.
Lack of referral systems, feedback mechanisms and follow-
up systems
Another issue mentioned is lack of functioning referral
systems and feedback-mechanisms especially in cases
where treatment is not offered at the primary health care
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referred to other clinics for care, may be lost between
the referring and the reference health facility, if neither
of the two follows up on whether she actually attends
the other institution. Similarly, when there is no feed-
back, the health care providers at the primary health
care level either often do not refer patients or if unwill-
ing to deal with GDM, may refer all cases to specialist
centres. Moreover, even when women are treated at the
same clinic where screening and diagnosis take place,
continuous follow-up before, during and after delivery
poses a challenge when no follow-up system is in place.
This is particularly true with regard to post-partum fol-
low-up and care, when the woman no longer has dia-
betes (but both the mother and child carry a very high
risk of future diabetes) and therefore is neither seen by
the obstetrician nor the diabetes specialist and is consid-
ered lost in the system. Nonetheless, both the mother
and child may be visiting the same health facility for the
well-baby clinic or immunization programme but the
system fails to identify them to provide continued coun-
selling because of lack of communication between differ-
ent departments.
Distance to health facility
Transportation to the health centre, both in terms of the
cost and the distance can also constitute a barrier to
early detection, diagnosis and treatment of GDM
according to respondents. The latter in particular can be
affected if the woman lives far from the health facility as
the woman then is required to attend the facility regu-
larly for monitoring. Travelling long distances under dif-
ficult travel conditions during advanced pregnancy has
many challenges and often requires that the women be
accompanied by an escort further adding to the cost and
feasibility. Therefore it is not surprising that women in
most LMIC particularly from rural areas reportedly have
much fewer antenatal visits.
Societal barriers
Perceptions of female body size and weight gain/loss in
relation to pregnancy
In some countries societal or cultural issues can hamper
treatment of GDM. Some respondents reported on local
perceptions of the desirable body size and shape of
women, not being conducive to motivating them to im-
prove eating habits and lose weight.
In Jamaica for example the ideal body size is big. . . So
when you are dealing with people who have a body
image which means that being large and heavy is
quite acceptable and maybe even attractive then it is
very difficult to try and get people to change their
diet.Respondent from project in Jamaica and Panama
Moreover, the issue of eating habits or losing weight dur-
ing pregnancy may be particularly sensitive in some areas.
People are not comfortable about the idea of not
gaining enough weight during pregnancy. They just
feel it means you are sick, that you have some sort of
disease. So they would want to put on some weight
during pregnancy, and when I say ‘some weight’ the
understanding of ‘putting on some weight’ can vary a
lot. So the idea of putting on weight during pregnancy
is something important to them. In urban areas it
won’t be the same, but in semi-urban and rural areas
they are not even expected to lose weight after giving
birth so they are sometimes overfed by the family
after delivery just to keep as big as they were during
pregnancy.
Respondent from project in Cameroon
Notions like these are not only problematic for treat-
ment of GDM, but also for the postpartum prevention
of future onset of type 2 diabetes.
Practices related to pregnant women’s diet
Other aspects related to diet were also brought out by the
respondents. For instance, one respondent from India
noted that it is customary to encourage pregnant women
to eat sweets and certain calorie dense, high fat snacks in
order for them to have enough energy, and people bring
such food as gifts when they visit. Thus, being on diet
where such things are banned can be a damper on the cel-
ebrations of the pregnancy and child birth within the fam-
ily and raise issues about the health of the young woman
thereby curbing her motivation to eat healthy.
Moreover, it was stated that it would not always be
considered appropriate for women in India to have spe-
cial low-calorie food for herself as she is expected to eat
the same as the rest of the family and not attract much
attention to herself and her needs.
Societal negligence of women’s health
Moreover, cultural notions about women and the im-
portance of their health also emerged as a barrier. Some
respondents explained that sometimes the woman’s fam-
ily may not consider her health to be important enough
to spend the extra money on healthy foods or treatment.
This may especially be the case after delivery as the
health of the woman is no longer seen as influencing the
health of the baby.
The health of women in India is the most neglected,
under-looked and deficient system of the whole
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bothered about the health of women whether it is
diabetes or anything else.
Respondent from project in Punjab, India
Lack of decision-making power among women regarding
their own health
In many cultures the woman herself does not make the
decisions even those concerning her own health - those
decisions are generally made by her husband and/or in-
laws, and if they make the decision that she should not
attend antenatal care or not have a specific test per-
formed it is very difficult for her to demand the test.
Whether a woman should go for antenatal check-up
or not is a decision taken by her husband, if she goes
there and she finds that there is some problem, what
kind of treatment, which doctors she should consult
etc. – all these decisions are being taken by the male
counterpart.
Respondent from project in multiple states of India
Fear of stigmatisation
Another impediment noted by some of the respondents
is that it can be highly stigmatising for a woman to be
diagnosed with GDM and the consequences of this for
her can be intimidating.
That fear inside her that everything will go wrong in
her life. Even if it is a risk or recommendation from a
doctor, a call from a doctor that ‘you are at risk of
getting diabetes’ or ‘the child will get affected with
some borderline hyperglycaemia’ would probably ruin
her family life - her husband would not look upon her
nicely or her mother-in-law will always be sarcastic in
her remarks.
Respondent from project in Punjab, India
Therefore, some women refuse the test simply because
they fear the consequences of its result. Yet, even among
women who are diagnosed with GDM postpartum test-
ing for overt diabetes is a challenge because of such fears
as a diagnosis of overt diabetes can be devastating for
her in financial, emotional and social terms.
Role of women in society
A number of more practical aspects were also men-
tioned as barriers to GDM detection, diagnosis and
treatment. Many of these are related to the woman’s role
in society - having to take care of the children and doing
other chores related to the household. Being too busy tohave time to attend antenatal care and GDM testing was
therefore cited as another barrier to ensure early detec-
tion of GDM. The issue revolves around both the time
consumed on the test and the time spent on transport to
and from the health centre. This is an even bigger issue
in terms of long term follow-up of women with GDM to
address future prevention of diabetes. Even if one tries
to establish follow-up mechanism through the well-baby
or vaccination programme it may not work because the
child may be brought to the clinic by somebody else – a
grandparent because the women is required to deal with
the household chores. Creating outreach home visit
based services are therefore very important in these
contexts.
Expectations that the pregnant woman move to her
maternal home for delivery
Some respondents noted that in their area, women tend
to move to their maternal home before delivery, adding
a further barrier to care delivery and follow-up as the
health care provider in the new area may not have the
full records, may not be well versed with the case or
may not have the training to deal with GDM.
Discussion
In this study a number of barriers to improving maternal
health related to GDM were identified, including lack of
trained health care providers - especially female doctors;
staff turnover and lack of standard protocols, consum-
ables and equipment; financing of health services and
treatment; lack of or poor referral systems, feedback
mechanisms and follow-up systems; distance to health
facility; perceptions of female body size and weight gain/
loss in relation to pregnancy; practices related to pregnant
women’s diet; societal negligence of women’s health; lack
of decision-making power among women regarding their
own health; stigmatisation; role of women in society and
expectations that the pregnant woman move to her mater-
nal home for delivery.
According to our knowledge only a few studies have
previously investigated barriers to management or post-
partum follow-up of women with diabetes during preg-
nancy [28-32], and none of these are from LMIC.
Although these studies were conducted in a setting very
different from our study there are certain similarities be-
tween the findings of these studies and ours. Hence,
Bennet et al., Collier et al., Mersereau et al. and Razee
et al. reported lack of concern about women’s health –
either because they feel healthy or because they have less
time for self-care due to the demands of the baby or
other responsibilities – as a barrier to GDM manage-
ment or postpartum follow-up [28-31]. Fear of being
diagnosed with overt diabetes was also identified by Ben-
net et al. as a barrier, although the reason behind this
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more the prospect of having to follow a strict diet and
regularly having to attend medical check-ups [28]. Col-
lier et al. also identified cost of health services, diabetic
supplies and healthy foods as barriers [29]. Finally, diffi-
culties in accessing care and cultural issues impeding
healthy diet and physical exercise were also identified by
Razee et al., Mersereau et al. and Collier et al. as barriers
to GDM management [29-31].
Considering that WHO in the 2006 World Health Re-
port concluded that there is a global shortage of almost
4.3 million doctors, nurses, midwives and support work-
ers [24] it is not surprising that turnover and lack of
trained health care providers is mentioned as a barrier
for GDM services. Seven of the projects included in this
study are implemented in countries where WHO assess
there is a critical shortage of health service providers
[24]. India is one of these countries and as only around
10% of doctors in South-East Asia are women [24] it is
not surprising that respondents from India noted lack of
female doctors as a particular problem.
However, as indicated by the respondents it is not only
a problem of numbers it is also a problem of skills and
training. Lack of knowledge has also been found to be a
problem for the management of type 2 diabetes in LMIC
[33,34]. Thus, to ensure that women with GDM receive
proper treatment, training of health care providers need
to be initiated or scaled up. Lack of standard protocols
on GDM diagnosis and management was also identified
as a barrier to early detection and proper management
of GDM. The lack of such protocols may reflect the lim-
ited attention that GDM has received in many LMIC,
the lack of international consensus on the diagnostic cri-
teria for GDM as well as existing protocols in their
current form not being feasible to implement in many
LMIC [19].
In addition, findings from this study also illustrate that
health services and systems are disorganised and inad-
equately financed and can work as barriers for achieving
specific health-related outcomes, in this case GDM de-
tection and treatment. This is far from new, but health
system planners and policy-makers should take these
structures and aspects into account when initiating
GDM services.
A substantial number of the barriers are societal or
culture-related e.g. expectations that the woman transfers
to her maternal home to deliver. While their relevance
may vary, such barriers remain important according to
our findings. Yet, they are largely beyond the realm of the
health sector and therefore have to be addressed outside it
through awareness and policies. Issues related to women’s
role in society and how much emphasis is given to their
health and well-being seems to be of particular concern
and the findings from this study indicate that much stillremains to be done to ensure women’s empowerment in-
cluding the right to control all aspects of their health as
stated in the Beijing Declaration adopted at the UN
Fourth World Conference on Women in 1995 [35].
Finally, in this study all participants were WDF project
partners and many of them are also practicing health
care providers. In order to further illuminate the issue it
would be important to undertake studies where women
and their families are interviewed about barriers and
facilitators for GDM services. Such a study should also
focus on barriers within the control of the individual in
addition to health system and societal/cultural barriers.
Conclusion
In this paper we examined barriers to GDM detection
and treatment in health systems and society. In order to
provide effective GDM services to improve maternal
health in LMIC, programmes have to consider and ad-
dress these barriers.
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